AIVITA Biomedical Receives $1.7 million in Funding as Part of UCI Awarded CIRM Grant to Treat Vision Loss
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
AIVITA Biomedical to Exhibit Skincare Products at Upcoming Conferences for Aesthetic and Skincare Medical Professionals
AIVITA Biomedical Announces First Patient Enrolled in Phase II Clinical Trial for Late-Stage Ovarian Cancer
